Lithera Appoints Thomas Wiggans to Board of Directors

04 Apr 2011

·www.biospace.com

IPO

SAN DIEGO, April 4, 2011 (GLOBE NEWSWIRE) -- Lithera, Inc. announced today the appointment of Thomas G. Wiggans to its Board of Directors."Lithera is making substantial progress with LIPO-102 by generating positive results with selective, non-ablative localized fat reduction," said George Mahaffey, President and Chief Executive Officer of Lithera. "These encouraging developments will allow us to enter the next stages of corporate development. I have worked closely with Tom before and believe that his experience in successfully building and leading dermatology companies will be of great value as we advance our programs."

Organizations

Neothetics, Inc.

Indications

Targets

Drugs

Fluticasone propionate/Salmeterol xinafoate

Chat with Hiro

Hot reports

GPRC5D Target Patent Research Report

Patsnap Synapse

Global Drug R&D Express (July 2024)

PatSnap Synapse

siRNA Drug Amvuttra Patent Research and Practical Operation Guide

Patsnap Synapse

Get started for free today!

Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.

Start your data trial now!

Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.